General
Sanofi to shoulder costs of death, adverse effects related to Dengvaxia
 

Sanofi to shoulder costs of death, adverse effects related to Dengvaxia

Shared by:

 
Sanofi Pasteur Asia-Pacific has committed to shoulder the costs of “death or adverse event that is causally-related” to Dengvaxia among  Filipino children inoculated with the dengue vaccine.
 
today.mims.com
 
31 Jan 2018 - General